Micro-X Limited (MCRXF)
OTCMKTS · Delayed Price · Currency is USD
0.1800
+0.0700 (63.64%)
At close: Feb 11, 2026
Micro-X Revenue
In the fiscal year ending June 30, 2025, Micro-X had annual revenue of 13.05M AUD, down -14.25%. Micro-X had revenue of 5.65M in the half year ending June 30, 2025, a decrease of -18.98%.
Revenue
13.05M AUD
Revenue Growth
-14.25%
P/S Ratio
5.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
43.78M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 13.05M | -2.17M | -14.25% |
| Jun 30, 2024 | 15.22M | 217.00K | 1.45% |
| Jun 30, 2023 | 15.01M | 6.04M | 67.28% |
| Jun 30, 2022 | 8.97M | 5.20M | 137.87% |
| Jun 30, 2021 | 3.77M | -480.00K | -11.29% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zomedica | 29.45M |
| Tian'an Technology Group | 2.12M |
| PetVivo Holdings | 1.41M |
| Positron | 486.45K |
| Guided Therapeutics | 178.00K |
| CS Diagnostics | 98.73K |
| Vivos | 48.62K |
| ALR Technologies SG | 25.54K |
Micro-X News
- 3 months ago - Micro-X Limited (MCRXF) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 3 months ago - Micro-X Limited (MCRXF) Q1 2026 Earnings Call Transcript - Seeking Alpha